U.S. markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7200-0.0700 (-2.51%)
At close: 04:00PM EDT
2.7000 -0.02 (-0.74%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close2.7900
Bid2.7000 x 36200
Ask2.7700 x 41800
Day's Range2.6500 - 2.8800
52 Week Range1.9500 - 28.8500
Avg. Volume12,611,218
Market Cap1.288B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.4230
Earnings DateAug 09, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CLOV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Clover Health Investments, Corp
    Analyst Report: BlackBerry LimitedBlackBerry, once known for being the world’s largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communication for enterprises. The firm provides endpoint management and protection to enterprises, specializing in regulated industries like government, as well as embedded software to the automotive, medical, and industrial markets.
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • Simply Wall St.

    Do Insiders Own Lots Of Shares In Clover Health Investments, Corp. (NASDAQ:CLOV)?

    Every investor in Clover Health Investments, Corp. ( NASDAQ:CLOV ) should be aware of the most powerful shareholder...

  • InvestorPlace

    Clover Health’s Earnings Losses Make It One to Avoid for Now

    Clover Health Investments’ (NASDAQ:CLOV) earnings continue being negative although some operating numbers seem to offer hope of a better stock price in the future for CLOV stock. For instance, in February the company announced that its 2022 revenues were expected to be more than $3 billion; this would be largely thanks to a forecast 90% yearly growth in the number of lives under management. Considering that the company reported that there was an increase of almost 300% year over year in the numb

  • GlobeNewswire

    Clover Health Reports First Quarter 2022 Financial Results

    First quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021 Lives under Clover Management grew to ~257,000 from ~66,000 year-over-year First quarter Insurance (Medicare Advantage) Medical Care Ratio (MCR) of 96.4% and Non-Insurance (Direct Contracting) MCR of 99.8% show significant improvement quarter-over-quarter Full-year 2022 revenue expected to be $3.0 billion to $3.4 billion Clover continues to expect 2022 Insurance MCR of 95% to 99% and a further step-w